Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887305428> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2887305428 abstract "Background: Non-dihydropyridine calcium channel blockers (non-DHP CCBs) are agents commonly used for ventricular rate control in patients with atrial fibrillation (AF). The agents have the property of combined cytochrome 3A4 and P-glycoprotein (P-gp) inhibition which may lead to increased drug exposure for oral anticoagulants that are substrates for these pathways. We investigated the safety and efficacy of rivaroxaban versus warfarin according to use of these agents. Objectives: This post-hoc analysis examined patient characteristics and compared outcomes between rivaroxaban and warfarin using Cox proportional hazards modeling according to the use of non-DHP CCBs at baseline in ROCKET AF (n=14,264). Methods and Results: At the time of randomization, 1308 patients (9.2%) were taking a non-DHP CCBs. Patients taking a non-DHP CCB were more likely to be female (45% vs. 39%), have diabetes (43% vs. 40%), and have a medical history of COPD (21% vs. 9%) while they were less likely to have a medical history of heart failure (49% vs. 64%), myocardial infarction (14% vs.18%) and had a lower mean CHADS 2 score (3.3 vs. 3.5). Non-DHP CCB use was not associated with an increased risk of stroke or non-CNS embolism (P=0.11) or the composite outcome of non-major clinically relevant or major bleeding (P=0.087). No significant difference was observed in the primary efficacy (stroke or non-CNS embolism; adjusted interaction P value=0.38) or primary safety outcome (non-major clinically relevant bleeding or major bleeding; adjusted interaction P value=0.14) between rivaroxaban and warfarin with non-DHP CCB use (Table). Conclusion: Non-DHP CCBs are commonly used medications for rate control in patients with AF. In spite of having the properties of combined P-gp and moderate CYP3A4 inhibition, use of these agents was not associated with a significant change in the efficacy or safety of rivaroxaban compared with warfarin in the ROCKET AF trial." @default.
- W2887305428 created "2018-08-22" @default.
- W2887305428 creator A5010554097 @default.
- W2887305428 creator A5011865225 @default.
- W2887305428 creator A5031776283 @default.
- W2887305428 creator A5046918258 @default.
- W2887305428 creator A5047596075 @default.
- W2887305428 creator A5047739481 @default.
- W2887305428 creator A5047841461 @default.
- W2887305428 creator A5057955577 @default.
- W2887305428 creator A5060271848 @default.
- W2887305428 creator A5063166017 @default.
- W2887305428 creator A5068185957 @default.
- W2887305428 creator A5078143516 @default.
- W2887305428 creator A5079201521 @default.
- W2887305428 creator A5086641554 @default.
- W2887305428 date "2015-11-10" @default.
- W2887305428 modified "2023-09-26" @default.
- W2887305428 title "Abstract 16902: Efficacy and Safety of Rivaroxaban versus Warfarin in Patients Taking Non-dihydropyridine Calcium Channel Blockers: Results From the ROCKET AF Trial" @default.
- W2887305428 doi "https://doi.org/10.1161/circ.132.suppl_3.16902" @default.
- W2887305428 hasPublicationYear "2015" @default.
- W2887305428 type Work @default.
- W2887305428 sameAs 2887305428 @default.
- W2887305428 citedByCount "0" @default.
- W2887305428 crossrefType "journal-article" @default.
- W2887305428 hasAuthorship W2887305428A5010554097 @default.
- W2887305428 hasAuthorship W2887305428A5011865225 @default.
- W2887305428 hasAuthorship W2887305428A5031776283 @default.
- W2887305428 hasAuthorship W2887305428A5046918258 @default.
- W2887305428 hasAuthorship W2887305428A5047596075 @default.
- W2887305428 hasAuthorship W2887305428A5047739481 @default.
- W2887305428 hasAuthorship W2887305428A5047841461 @default.
- W2887305428 hasAuthorship W2887305428A5057955577 @default.
- W2887305428 hasAuthorship W2887305428A5060271848 @default.
- W2887305428 hasAuthorship W2887305428A5063166017 @default.
- W2887305428 hasAuthorship W2887305428A5068185957 @default.
- W2887305428 hasAuthorship W2887305428A5078143516 @default.
- W2887305428 hasAuthorship W2887305428A5079201521 @default.
- W2887305428 hasAuthorship W2887305428A5086641554 @default.
- W2887305428 hasConcept C126322002 @default.
- W2887305428 hasConcept C127413603 @default.
- W2887305428 hasConcept C164705383 @default.
- W2887305428 hasConcept C2776301958 @default.
- W2887305428 hasConcept C2777185221 @default.
- W2887305428 hasConcept C2778661090 @default.
- W2887305428 hasConcept C2779161974 @default.
- W2887305428 hasConcept C2780645631 @default.
- W2887305428 hasConcept C2781212610 @default.
- W2887305428 hasConcept C500558357 @default.
- W2887305428 hasConcept C519063684 @default.
- W2887305428 hasConcept C71924100 @default.
- W2887305428 hasConcept C78519656 @default.
- W2887305428 hasConceptScore W2887305428C126322002 @default.
- W2887305428 hasConceptScore W2887305428C127413603 @default.
- W2887305428 hasConceptScore W2887305428C164705383 @default.
- W2887305428 hasConceptScore W2887305428C2776301958 @default.
- W2887305428 hasConceptScore W2887305428C2777185221 @default.
- W2887305428 hasConceptScore W2887305428C2778661090 @default.
- W2887305428 hasConceptScore W2887305428C2779161974 @default.
- W2887305428 hasConceptScore W2887305428C2780645631 @default.
- W2887305428 hasConceptScore W2887305428C2781212610 @default.
- W2887305428 hasConceptScore W2887305428C500558357 @default.
- W2887305428 hasConceptScore W2887305428C519063684 @default.
- W2887305428 hasConceptScore W2887305428C71924100 @default.
- W2887305428 hasConceptScore W2887305428C78519656 @default.
- W2887305428 hasIssue "suppl_3" @default.
- W2887305428 hasLocation W28873054281 @default.
- W2887305428 hasOpenAccess W2887305428 @default.
- W2887305428 hasPrimaryLocation W28873054281 @default.
- W2887305428 hasRelatedWork W1523628474 @default.
- W2887305428 hasRelatedWork W1964135733 @default.
- W2887305428 hasRelatedWork W1969345438 @default.
- W2887305428 hasRelatedWork W1973103195 @default.
- W2887305428 hasRelatedWork W198485852 @default.
- W2887305428 hasRelatedWork W2030798886 @default.
- W2887305428 hasRelatedWork W2047376380 @default.
- W2887305428 hasRelatedWork W2064102714 @default.
- W2887305428 hasRelatedWork W2165450482 @default.
- W2887305428 hasRelatedWork W2329382823 @default.
- W2887305428 hasRelatedWork W2411364734 @default.
- W2887305428 hasRelatedWork W2413591712 @default.
- W2887305428 hasRelatedWork W2489309004 @default.
- W2887305428 hasRelatedWork W2599173896 @default.
- W2887305428 hasRelatedWork W2619557274 @default.
- W2887305428 hasRelatedWork W2799741221 @default.
- W2887305428 hasRelatedWork W2990272296 @default.
- W2887305428 hasRelatedWork W3024219013 @default.
- W2887305428 hasRelatedWork W3156170108 @default.
- W2887305428 hasRelatedWork W1570376102 @default.
- W2887305428 hasVolume "132" @default.
- W2887305428 isParatext "false" @default.
- W2887305428 isRetracted "false" @default.
- W2887305428 magId "2887305428" @default.
- W2887305428 workType "article" @default.